Advertisement

Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

  • Daniel H. Johnson
  • Chrystia M. Zobniw
  • Van A. Trinh
  • Junsheng Ma
  • Roland L. Bassett Jr
  • Noha Abdel-Wahab
  • Jaime Anderson
  • Jennifer E. Davis
  • Jocelyn Joseph
  • Marc Uemura
  • Ali Noman
  • Hamzah Abu-Sbeih
  • Cassian Yee
  • Rodabe Amaria
  • Sapna Patel
  • Hussein Tawbi
  • Isabella C. Glitza
  • Michael A. Davies
  • Michael K. Wong
  • Scott Woodman
  • Wen-Jen Hwu
  • Patrick Hwu
  • Yinghong Wang
  • Adi DiabEmail author
Open Access
Correction
  • 72 Downloads

Correction to: J Immunother Cancer

  https://doi.org/10.1186/s40425-018-0412-0

Following publication of the original article [1], the authors reported an error in their listed affiliations. This error was introduced during typesetting and the publisher apologizes to readers and the authors for the inconvenience.

In this Correction the authors are listed with their correct affiliations below.

Daniel H Johnson1, Chrystia M Zobniw2, Van A Trinh2, Junsheng Ma3, Roland L Bassett Jr3, Noha Abdel-Wahab4,5, Jaime Anderson2, Jennifer E Davis6, Jocelyn Joseph2, Marc Uemura1, Ali Noman7, Hamzah Abu-Sbeih7, Cassian Yee1, Rodabe Amaria1, Sapna Patel1, Hussein Tawbi1, Isabella C Glitza1, Michael A Davies1, Michael K Wong1, Scott Woodman1, Wen-Jen Hwu1, Patrick Hwu1, Yinghong Wang7 and Adi Diab1

1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2Division of Pharmacy, Clinical Section, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

4Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

5Department of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt

6Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

7Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Reference

  1. 1.
    Johnson DH, et al. Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis. J Immunother Cancer. 2018;6:103  https://doi.org/10.1186/s40425-018-0412-0.CrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Daniel H. Johnson
    • 1
  • Chrystia M. Zobniw
    • 2
  • Van A. Trinh
    • 2
  • Junsheng Ma
    • 3
  • Roland L. Bassett Jr
    • 3
  • Noha Abdel-Wahab
    • 4
    • 5
  • Jaime Anderson
    • 2
  • Jennifer E. Davis
    • 6
  • Jocelyn Joseph
    • 2
  • Marc Uemura
    • 1
  • Ali Noman
    • 7
  • Hamzah Abu-Sbeih
    • 7
  • Cassian Yee
    • 1
  • Rodabe Amaria
    • 1
  • Sapna Patel
    • 1
  • Hussein Tawbi
    • 1
  • Isabella C. Glitza
    • 1
  • Michael A. Davies
    • 1
  • Michael K. Wong
    • 1
  • Scott Woodman
    • 1
  • Wen-Jen Hwu
    • 1
  • Patrick Hwu
    • 1
  • Yinghong Wang
    • 7
  • Adi Diab
    • 1
    Email author
  1. 1.Department of Melanoma Medical OncologyThe University of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.Division of Pharmacy, Clinical SectionThe University of Texas MD Anderson Cancer CenterHoustonUSA
  3. 3.Department of BiostatisticsThe University of Texas MD Anderson Cancer CenterHoustonUSA
  4. 4.Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer CenterHoustonUSA
  5. 5.Department of Rheumatology and Rehabilitation, Faculty of MedicineAssiut University HospitalsAssiutEgypt
  6. 6.Department of Epidemiology, Division of Cancer Prevention and Population SciencesThe University of Texas MD Anderson Cancer CenterHoustonUSA
  7. 7.Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal MedicineThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations